Pharma & Healthcare – the latest on DEA probe, False Claims Act, Pfizer and more.
Costco Wholesale Corp (
COST.O) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA. The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected… [
Read More ]
The Supreme Court is considering an appeal from the 4th Circuit regarding the specificity necessary when pleading false claims act cases. The issue has serious implications for whistleblowers who can only document indirect frauds against government programs… [
Read More ]
A new type of lipid-lowering drug being developed by Sanofi and Regeneron Pharmaceuticals cut cholesterol levels by about half in its first late-stage clinical trial, the companies will announce on Wednesday. The drug, called alirocumab, is one of a new class of potentially powerful cholesterol fighters that have excited doctors and investors alike, spurring a heated
race to market among Sanofi, Amgen, Pfizer and other companies… [
Read More ]
Pfizer has received European Commission approval for updates to the summary of product characteristics (SmPC) for its pneumococcal conjugate vaccine (PCV) Prevenar 13, regarding its use in certain high-risk populations. The updated label now contains information about the use of Prevenar 13 in preterm infants, children and adolescents with sickle cell disease who were earlier treated with the 23-valent pneumococcal polysaccharide vaccine…[
Read More]
Related Events
For a complete list of all Pharma related events:
Click Here
For a complete list of all Healthcare related events:
Click Here
For a complete list of all Pharma conference proceedings:
Click Here
For a complete list of all Healthcare conference proceedings:
Click Here Tags: FDA, Legal News, Pharma, Weekly Industry News